News | Image Guided Radiation Therapy (IGRT) | June 19, 2017

Henry Ford Cancer Institute First in World to Install Viewray MRIdian Linac

MRI-guided radiation therapy system combines real-time tumor assessment with linear accelerator delivery

Henry Ford Cancer Institute First in World to Install Viewray MRIdian Linac

June 19, 2017 — The Henry Ford Cancer Institute is the first in Michigan – and first in the world – to offer patients advanced radiation therapy with the ViewRay MRIdian Linac system. The system uses a U.S. Food and Drug Administration (FDA)-approved real-time magnetic resonance imaging (MRI) and linear accelerator delivery for more precise and accurate radiation treatment.

The ViewRay MRIdian Linac is the world's first and only FDA-approved commercially available linear accelerator-based MRI-guided radiation therapy system that can image and treat patients simultaneously, according to Viewray. The FDA approved the company's next-generation model for use in February.

The same model is being installed at the Cancer Institute at Henry Ford Medical Center-Cottage in Grosse Pointe Farms. It will be ready for treating patients in July 2017.

Benjamin Movsas, M.D., chair of the Department of Radiation Oncology at the Cancer Institute and a national expert, said the system offers "game-changing technology" in radiation therapy.

"This is the future in our field," Movsas said. "This technology will allow us to optimize in real-time the delivery of radiation."

Movsas said while the system will be used to treat all types of cancers anywhere in the body, it is especially beneficial for tumors where there is typically movement during treatment, including tumors in the liver, pancreas, adrenal and lung. Other types of cancer this advanced system will deliver a new level of care to include breast, prostate, kidney and gynecologic cancers, among others.

Indrin Chetty, Ph.D., division head of Physics in Radiation Oncology, said the MRIdian Linac system further enhances radiation therapy with:

  • Personalized treatment. By continuously observing and assessing the patient's tumor and internal organs, clinicians can tailor treatment to each individual;
  • Precision and accuracy. High-quality images and continuous soft-tissue imaging are provided while the radiation beam is on; and
  • Real-time imaging. When clinicians can clearly see the target and watch where the radiation is being delivered, they are better able to adapt to changes in the patient's anatomy.

Over the years, technology has improved the accuracy of radiation treatment while protecting surrounding healthy tissue. However, trying to accommodate for the natural movement of a tumor and the body's internal organs during treatment has been elusive.

The ViewRay system combines the effectiveness of MRI, which produces high-quality images of organs and structures inside the body, with a linear accelerator to map out a therapy plan and deliver radiation at the intended target, while allowing for refinements to be made in real-time during treatment. The result is a more accurate, precise treatment.

For more information: www.viewray.com

Related Content

Hippocampal Sparing Prevents Whole-Brain Radiotherapy Cognitive Side Effects
News | Radiation Therapy | October 23, 2018
Whole-brain radiotherapy can be delivered more safely to patients with brain metastases by avoiding the hippocampus,...
Artificial intelligence (AI) will not force specialists in radiation oncology from their jobs but rather make them better at the jobs only they can do, said speakers at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas.
Feature | Artificial Intelligence | October 22, 2018 | By Greg Freiherr
Artificial intelligence (AI) will not force specialists in radiation oncology from their jobs but rather make them be
News | Prostate Cancer | October 22, 2018
The first report of a large, international clinical trial shows that, for men who show signs of...

Image courtesy of Vital Images

News | ASTRO | October 22, 2018
Treatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one
Fewer, larger individual doses of radiation lead to similar adverse effects to normal tissue after 10 years as with conventional radiation therapy for early breast cancer
News | ASTRO | October 22, 2018
In a 10-year study of women who received radiation therapy to treat early-stage breast cancer, those receiving fewer,
Patients whose cancer has not spread far past the lungs may benefit from targeting tumor sites with radiation or surgery after initial treatment, according to ASTRO study
News | ASTRO | October 21, 2018
Adding radiation therapy or surgery to systemic therapy for stage IV lung cancer patients whose cancer has spread to
DCIS, ductal carcinoma in situ, radiation therapy, survival benefit, Brigham and Women's Hospital study

Image courtesy of Barco

News | ASTRO | October 21, 2018
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservatio
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. #ASTRO2018 #ASTRO #ASTRO18

The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. 

News | Computed Tomography (CT) | October 19, 2018
October 19, 2018 – At the 2018 American Society of...
IBA's Proteus system and proton therapy solutions will be discussed at ASTRO 2018. #ASTRO18 #ASTRO #ASTRO2018
News | Proton Therapy | October 19, 2018
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and t